We break down the current state of frontotemporal dementia, from bvFTD to PPA, and why 'promising' therapies are still far ...

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a ...

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

Researchers at Université Savoie Mont Blanc, Radboud University and the University of Oxford's Wellcome Center for ...

There’s rarely good news about Alzheimer’s disease, but a failed study may open the door to more research about vascular ...

A key gene known for its role in Alzheimer's disease has been found to play a second, damaging role in a different brain ...

"While semaglutide did not demonstrate efficacy in slowing the progression of Alzheimer's disease, the extensive body of ...

An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.

The AFA encourages family caregivers to use T.H.A.N.K.S. to create a dementia-friendly Thanksgiving celebration for their ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

The biomarker improvements in the EVOKE studies are worth noting, observed Howard Fillit, MD, of the Alzheimer's Drug ...

While the Phase III results confirm prior analyst sentiments, a KOL notes that GLP-1RAs could still show potential in the ...